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Behavioral/Cognitive
Corticosterone Acts in the Nucleus Accumbens to Enhance
Dopamine Signaling and Potentiate Reinstatement of
Cocaine Seeking
Evan N. Graf, Robert A. Wheeler, David A. Baker, Amanda L. Ebben, Jonathan E. Hill, Jayme R. McReynolds,
Mykel A. Robble, Oliver Vranjkovic, Daniel S. Wheeler, John R. Mantsch,* and Paul J. Gasser*
Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201-1881
Stressful life events are important contributors to relapse in recovering cocaine addicts, but the mechanisms by which they influence
motivational systems are poorly understood. Studies suggest that stress may “set the stage” for relapse by increasing the sensitivity of
brain reward circuits to drug-associated stimuli. We examined the effects of stress and corticosterone on behavioral and neurochemical
responses of rats to a cocaine prime after cocaine self-administration and extinction. Exposure of rats to acute electric footshock stress
did not by itself reinstate drug-seeking behavior but potentiated reinstatement in response to a subthreshold dose of cocaine. This effect
of stresswas not observed in adrenalectomized animals, andwas reproduced in nonstressed animals by administration of corticosterone
at a dose that reproduced stress-induced plasma levels. Pretreatment with the glucocorticoid receptor antagonist RU38486 did not block
the corticosterone effect. Corticosterone potentiated cocaine-induced increases in extracellular dopamine in the nucleus accumbens
(NAc), and pharmacological blockade of NAc dopamine receptors blocked corticosterone-induced potentiation of reinstatement. Intra-
accumbens administration of corticosterone reproduced the behavioral effects of stress and systemic corticosterone. Corticosterone
treatment acutely decreased NAc dopamine clearance measured by fast-scan cyclic voltammetry, suggesting that inhibition of uptake2-
mediated dopamine clearance may underlie corticosterone effects. Consistent with this hypothesis, intra-accumbens administration of
the uptake2 inhibitor normetanephrine potentiated cocaine-induced reinstatement. Expression of organic cation transporter 3, a
corticosterone-sensitive uptake2 transporter, was detected on NAc neurons. These findings reveal a novel mechanism by which stress
hormones can rapidly regulate dopamine signaling and contribute to the impact of stress on drug intake.
Introduction
Cocaine addicts report that craving responses to drug-associated
stimuli are intensified during periods of stress, resulting in
heightened susceptibility to relapse of drug use (Sinha, 2001; Hy-
man et al., 2006). These reports are paralleled by preclinical find-
ings that stress can potentiate the reinstatement of compulsive
drug-seeking behavior by drug-associated cues in rodents (Shel-
ton and Beardsley, 2005; Feltenstein and See, 2006; Buffalari and
See, 2009). Together, these studies suggest that stress may act as a
“stage-setter,” inducing state-dependent changes in the sensitiv-
ity of brain reward circuits to the reinforcing properties of drugs
(Preston and Epstein, 2011) and enhancing the potency of drugs
of abuse or drug-associated cues to induce relapse. Thus, inter-
actions between pathways activated by stress and by cocaine-
associated stimuli are likely to be critical determinants of relapse
vulnerability. However, the potential mechanisms underlying
these interactions have not been well studied.
In addition to directly engagingmotivational circuitry, stress-
ful stimuli activate the hypothalamic-pituitary-adrenocortical
(HPA) axis, resulting in the release of glucocorticoid hormones,
corticosterone in rodents and cortisol in humans. Clinical and
preclinical studies suggest a complex relationship between gluco-
corticoids and drug relapse. In human addicts, stress-, cue-, and
drug-induced craving for cocaine is associated with elevated cor-
tisol (Berger et al., 1996; Reid et al., 2003; Sinha et al., 2003) and
heightened HPA reactivity can predict relapse susceptibility
(Sinha et al., 2006, 2011; Fatseas et al., 2011; McKee et al., 2011).
In rodents, glucocorticoids can enhance behavioral and neuro-
chemical responses to drugs of abuse (Piazza et al., 1996;
Marinelli et al., 1997; Barrot et al., 2000), but eliminating in-
creases in glucocorticoids does not prevent stress- or cocaine-
induced reinstatement of compulsive drug seeking in rats (Erb et
al., 1998; Mantsch et al., 2008; Graf et al., 2011) or cocaine-
induced reinstatement in monkeys (Lee et al., 2003), and studies
examining the ability of elevated glucocorticoids alone to rein-
state cocaine seeking have yielded mixed results (Deroche et al.,
1997; Lee et al., 2003; Shalev et al., 2003). Together, these studies
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indicate that, although glucocorticoids alone may not drive re-
lapse, they do interact with drugs and drug-associated stimuli to
influence the likelihood of drug use. In the present studies, we
examined the effects of stress and glucocorticoids on the behav-
ioral and neurochemical responses of rats to a relapse-promoting
stimulus.
Materials andMethods
Animals. Adult male Sprague Dawley rats (Harlan Laboratories), weigh-
ing 275–325 g,were housed individually in a temperature- andhumidity-
controlled, Association for Assessment and Accreditation of Laboratory
Animal Care-accredited vivarium under a 12 h/12 h reversed light-dark
cycle (lights off at 0700 h) with ad libitum access to food and water.
Procedures were performed in accordance with theNational Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Jugular catheterization. Rats received indwelling jugular catheters un-
der ketamine/xylazine (100mg/kg; 2mg/kg, i.p.) anesthesia as previously
described (Graf et al., 2011). Lines were connected to syringe pumps
(Razel) via fluid swivels (Instech Laboratory) suspended above the
chambers. Swivel/leash assemblies were balanced to permit unre-
strained movement.
Cocaine self-administration, extinction, and reinstatement. Self-
administration was conducted using computer-interfaced operant con-
ditioning chambers contained in sound-attenuating cubicles (Med
Associates). Rats were trained to self-administer cocaine (0.5 mg/kg/200
l, i.v.) by pressing a lever under a fixed ratio one schedule during daily
2 h sessions. Cocaine infusions were accompanied by illumination of a
light followed by a 25 s timeout period during which the light was extin-
guished but the lever remained extended. Responding on a second, inac-
tive lever was also recorded. Once stable responding was observed
(10% variation in daily responding over3 consecutive sessions), rats
underwent an additional 14 daily self-administration sessions followed
by extinction training consisting of daily sessions during which the co-
caine solution was replaced with saline. Once extinction criterion was
met (10 active responses/session across 3 sessions), each rat was tested
for reinstatement. Reinstatement sessions were identical to extinction,
except that they were preceded by the delivery of an experimental treat-
ment (e.g., footshock, corticosterone, or vehicle) followed by noncon-
tingent intraperitoneal injection of cocaine (2.5 mg/kg) or saline.
Reinstatement was defined as an increase in responding on the lever
previously reinforced by cocaine comparedwith the preceding extinction
session. Inactive lever pressing was recorded during reinstatement but is
not reported because of a lack of significant effects.
Behavioral testing. Behavioral experiments were conducted during the
light phase. Each rat in the reinstatement experiments was tested four
times in a counterbalanced sequence, such that each rat received each
treatment. Between consecutive reinstatement tests, rats underwent ad-
ditional extinction sessions until they again met extinction criterion.
Microdialysis. Drug-naive rats were anesthetized under ketamine/xy-
lazine anesthesia and implanted with bilateral guide cannulae (20 gauge;
14mm;PlasticsOne) directed at the nucleus accumbens (NAc), using the
following coordinates (Paxinos and Watson, 1998):0.9 mm AP,2.5
mmML to bregma,4.4 mm from the surface of the skull, at an angle 6°
fromvertical, and allowed to recover for 5 d. The night before testing, rats
were housed in self-administration chambers. The following day, micro-
dialysis probes constructed as previously described (Madayag et al.,
2010) were inserted into guide cannulae and dialysis buffer (5 mM glu-
cose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM MgCl2, and 0.15% PBS, pH
7.4) was pumped through at a rate of 1 l/min for 3 h to allow neu-
rotransmitter levels to stabilize. Samples were collected at 20 min inter-
vals throughout the study. Dopamine concentrations were quantified by
comparing peak heights from samples and external standards using
HPLC coupled to electrochemical detection. Themobile phase consisted
of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM citric
acid, 3 mM SDS, and 50 M EDTA, pH 5.6. Dopamine was separated
using a reversed-phase column (3 m; 80 3.2 mm; ESA) and detected
using an ESA Coulochem II detector coupled to two electrodes set a
t0.075 V and0.25 V, respectively.
Experiment 1: effects of stress on cocaine-primed reinstatement. After
extinction training, rats (n  7) were placed into self-administration
chambers for 15 min, during which they received either no shocks (con-
trol) or a series of intermittent uncontrollable electric footshocks (0.5
mA, 0.5 s duration, mean intershock interval  40 s, range 10–70 s)
through the grid floor. Response levers were retracted during this period.
After footshock, rats received an injection of cocaine (2.5 mg/kg, i.p.) or
saline, and were tested for reinstatement.
Experiment 2: effects of adrenalectomy on footshock- and cocaine-primed
reinstatement. After acquiring stable self-administration, rats (n  6)
underwent bilateral adrenalectomy under ketamine/xylazine anesthesia
and were implanted with subcutaneous 25% corticosterone (Sigma-
Aldrich) pellets in the nape of the neck, which results in plasma cortico-
sterone concentrations approximating those observed at the nadir of the
diurnal cycle (Mantsch et al., 2008). Rats received 0.025% corticosterone
in the drinking water (ethanol concentration  0.0001%). During the
active phase, whenmost drinking occurs, this elevates plasma corticoste-
rone concentrations to those observed at the circadian peak (Mantsch et
al., 2008). Drinkingwater also contained 0.9%NaCl. Upon recovery, rats
underwent extinction training, followed by reinstatement testing.
Experiment 3: effects of corticosterone on basal and cocaine-primed rein-
statement. After extinction training, adrenal-intact rats (n  6) were
tested for reinstatement after an injection of corticosterone (2 mg/kg,
i.p.) or vehicle (0.03% EtOH, i.p.) 40 min before administration of co-
caine (2.5 mg/kg, i.p.) or saline. This dose of corticosterone reproduces
electric footshock-induced plasma levels (Table 1).
Experiment 4: effects of RU38486 and corticosterone on cocaine-primed
reinstatement. To test the role of glucocorticoid receptor (GR) in
corticosterone-induced potentiation of reinstatement, adrenal-intact
rats (n  10) received an injection of RU38486 (12.5 mg/kg, s.c.) or
vehicle (45% hydroxypropyl -cyclodextrin) 1 h before intraperitoneal
administration of corticosterone (2 mg/kg) or vehicle (0.03% ethanol).
Forty minutes later, rats were tested for cocaine-induced reinstatement
(2.5 mg/kg, i.p.).
Experiment 5: effects of corticosterone on cocaine-induced increases in
NAc dopamine. After collection of baseline samples, rats received an in-
jection of corticosterone (2.0 mg/kg, i.p.; n  13) or vehicle (0.03%
EtOH; n  12), followed 40 min later by an injection of cocaine (2.5
mg/kg, i.p.). Samples were collected for an additional 2 h. After the study,
rats were anesthetized with an overdose of pentobarbital (60 mg/kg, i.p.)
and transcardially perfused with 0.9% saline and 2.5% formalin. Brains
were removed, postfixed, and sectioned in the coronal plane (100 m)
for verification of probe placement.
Experiment 6: effects of intra-accumbens fluphenazine on corticosterone-
induced potentiation of cocaine-primed reinstatement. At the time of jug-
ular implantation, rats received bilateral 11mm, 26-gauge cannula aimed
0.5 mm above the target region, and the following coordinates were used
(Paxinos and Watson, 1998): core: anteroposterior (AP), 1.0; medio-
lateral (ML),2.2; dorsoventral (DV),6.5 at 0°; shell: AP,2.5; ML,
0.75; DV,6.5 at 0°. Rats received bilateral injections of the nonselec-
tive dopamine receptor antagonist, fluphenazine (30 nmol/0.3 l/side
over 1 min) or vehicle (aCSF) into the NAc core (n 6) or shell (n 7)
25 min after administration of corticosterone (2 mg/kg, i.p.) and 15 min
before low-dose cocaine (2.5 mg/kg, i.p.) administration and reinstate-
ment testing.
Experiment 7: effects of intra-accumbens corticosterone on cocaine-
primed reinstatement. Rats with cannulae aimed at the NAc core (n 6)
or shell (n  6) received intra-accumbens injections of hydroxypropyl
-cyclodextrin-complexed corticosterone (0.05 g/0.3 l/side over 1
min) or vehicle (aCSF) 15min before administration of low-dose cocaine
(2.5 mg/kg, i.p.) or saline and reinstatement testing.
Table 1. Summary of treatment effects on plasma corticosterone concentrations
Control Electric footshock
Corticosterone
(2.0 mg/kg)
Vehicle 122 28 265 57 384 34
Cocaine (2.5 mg/kg) 129 32 244 47 360 46
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Experiment 8: effects of intra-accumbens normetanephrine on cocaine-
primed reinstatement. Rats with cannulae aimed at the NAc shell (n 6)
received intra-accumbens injections of the nonglucocorticoid OCT3 in-
hibitor, normetanephrine (25 ng/0.3 l/side over 1 min) or vehicle
(aCSF) 15 min before administration of low-dose cocaine (2.5 mg/kg,
i.p.) or saline and reinstatement testing.
Voltammetry. Rats (n 5 experimental, 5 control) were anesthetized
with urethane (1.5 g/kg, i.p.; Sigma-Aldrich) and placed in a stereotaxic
frame (David Kopf Instruments). AP, ML, and DV positions were refer-
enced from bregma. The dura mater was punctured, carefully removed,
and a single carbon-fiber microelectrode was lowered into the NAc shell
(AP, 1.7 mm; ML, 0.8 mm; DV, 6.0–8.0 mm), coordinates taken
from an atlas of Paxinos andWatson (1998). The NAc shell was targeted
based on our previous studies, which demonstrated that, althoughOCT3
is expressed in both the core and shell of the NAc, it is expressed more
densely in the shell (Gasser et al., 2009). An Ag/AgCl reference electrode
was placed in the contralateral cortex. Electrical stimulation was accom-
plished with a bipolar, stainless-steel electrode (0.2 mm in diameter,
Plastics One) placed in the ventral tegmental area (AP, 5.2 mm; ML,
1.0 mm; DV, 8.0–9.0 mm). The tips of the bipolar electrode were
separated by1.0 mm.
Electrical stimulation. Computer-generated stimulus trains (NL 800A,
Neurolog, Medical Systems) were optically isolated from the electro-
chemical system. Trains consisted of 24 biphasic pulses (300 A, 2 ms
each phase) with a stimulation frequency of 60 Hz applied through the
bipolar electrode. An interval of 3 min was allowed to elapse between
electrical stimulations to ensure reproducible catecholamine release with
each stimulation.
Voltammetric procedures. Voltammetric procedures have been de-
scribed in detail previously (Heien et al., 2005). Briefly, glass-encased,
cylindrical carbon-fibermicroelectrodes (T-650 carbon fibers, 5.1m in
nominal diameter, Thornel, Amoco) with an exposed length of 75–100
m and Ag/AgCl reference electrodes were prepared. The fiber was held
at0.4 V against Ag/AgCl between scans and then driven to1.3 V and
back in a triangular fashion at 400 V/s for each voltammetric measure-
ment. Application of this triangle waveform causes oxidation and reduc-
tion of chemical species that are electroactive within this potential range,
producing a change in current at the carbon fiber. Dopamine was iden-
tified by plotting changes in current against applied potential to produce
a cyclic voltammogram. Current arising from electrode surface processes
was subtracted as background. Background-subtracted cyclic voltammo-
grams were obtained by digitally subtracting voltammograms collected
during stimulation from those collected during baseline recording. Vol-
tammetric responses were viewed as color plots with the abscissa as volt-
age, the ordinate as acquisition time, and the current encoded in color.
Temporal responses were determined by monitoring the current at the
peak oxidation potential for dopamine by principal component regres-
sion (Heien et al., 2005). Because the carbon-fiber microelectrode was
used to lesion the brain and mark the precise recording site, postcalibra-
tion of the electrode was impossible. Instead, postcalibration factors/
carbon fiber area (6.9 0.3 pA/[mol/Lm2]) were used on the basis
of the average response data obtained from calibrating multiple elec-
trodes in the manner of Park et al. (2010).
Data analysis. The Demon Voltammetry software suite was used to
analyze all data in the manner of Yorgason et al. (2011).  was extrapo-
lated from an exponential fit of the decay curve, as the point of 63.2%
decline in the signal. Full-width at half-height was defined as the time
between themidpoint of decline of the decay curve extended back in time
to the intersecting point of incline of the ascending curve of the dopa-
mine signal. Km is the apparent affinity of dopamine for transporters,
solved for from the Michaelis-Menten equation (Wightman et al., 1988;
Yorgason et al., 2011). The decay times 20 and 80 were defined as the
time to 20% and 80% signal reductions in the decay curve. Data are
represented as mean change after treatment SEM.
Immunofluorescence. For immunodetection of OCT3, an affinity-
isolated antibody (rabbit anti-OCT3, catalog #OCT31A, Alpha Diag-
nostics International) raised against an 18-amino acid sequence
in the large intracellular loop of rat OCT3 (amino acids 313–330:
HLSSNYSEITVTDEEVSN) was used. This amino acid sequence is 100%
conserved in mouse and rat OCT3 and has no significant sequence ho-
mology with other OCTs or with any organic cation/carnitine transport-
ers. The specificity of this antibody was confirmed previously in
immunohistochemical and immunofluorescence applications (Vialou et
al., 2004; Lips et al., 2005; Gasser et al., 2006, 2009). Additional proteins
were detected using primary antibodies directed against tyrosine hydrox-
ylase (MAB 318, Millipore; diluted 1:1600), dopamine D1 receptor
(MAB 5290, Millipore; diluted 1:500), and -III tubulin (ab 7751,
Abcam; diluted 1:1200). Primary antibodies were detected using
AlexaFluor-594-conjugated donkey anti-rabbit and AlexaFluor-488-
conjugated donkey anti-mouse IgG antibodies (1:200; Invitrogen). Pho-
tomicrographs were acquired using a Retiga 2000R digital camera
(QImaging) on a Nikon 80i microscope using NIS Elements software
(Nikon Instruments). Each combination of antibodies was used in at
least three independent studies with similar results.
Statistical analysis. Statistical analyses were conducted using IBMSPSS
Statistics software. Sample sizes (n) were determined by expected effect
sizes and the power of the analysis. Statistical significance was deter-
mined using ANOVA or Student’s t tests (two-tailed) followed, when
appropriate, by further analyses of main effects using ANOVA and/or
post hoc testing using Bonferroni-corrected t tests. Normality testing for
all data was conducted using the Shapiro-Wilk test; and in all cases, data
were determined to be sufficiently normal to merit parametric analysis.
For within-subjects analyses, sphericity of data was confirmed using the
Mauchly’s test. For between-subjects analyses, homogeneity of data was
confirmed using the Levene’s test.
Results
Stress and corticosterone potentiate cocaine-induced
reinstatement of drug-seeking behavior
We demonstrate here that a dose of cocaine (2.5 mg/kg, i.p.),
which is insufficient to reinstate extinguished cocaine seeking
under baseline conditions, produces robust reinstatement when
delivered after exposure to an acute stressor, uncontrollable elec-
tric footshock. Significant reinstatement was observed when rats
were tested for cocaine-induced reinstatement after footshock
(post hoc, p  0.034 vs extinction) but not when rats received
cocaine alone or footshock in combinationwith a saline injection
(two-way ANOVA; significant footshock  reinstatement con-
dition interaction: F(3,18) 3.424; p 0.04) (Fig. 1A).
To test the hypothesis that the observed potentiation of rein-
statement by footshock was mediated by elevated corticosterone,
we conducted two experiments. First, we tested for footshock-
potentiated reinstatement in a group of adrenalectomized rats in
which plasma corticosterone concentrations were maintained at
basal (nonstress) concentrations. Adrenalectomy was performed
after acquisition of self-administration but before reinstatement
testing. Footshock failed to potentiate cocaine-induced reinstate-
ment in adrenalectomized rats (two-way ANOVA; no significant
footshock reinstatement condition interaction: F(3,21) 0.976;
p 0.423) (Fig. 1B), indicating that stress-induced potentiation
of cocaine-seeking behavior requires elevation of corticosterone
concentrations to stress levels. Second, we examined (in adrenal-
intact rats) the effects of acute stress-level corticosterone treat-
ment on cocaine-primed reinstatement in the absence of stress.
In this study, administration of corticosterone at a dose (2mg/kg,
i.p.) that produced stress levels in plasma (Table 1) was sufficient
to potentiate cocaine-induced reinstatement in the absence of
stress (Fig. 1C). Like footshock, corticosterone alone (before a
saline injection) failed to reinstate cocaine seeking but potenti-
ated reinstatement in response to low-dose cocaine (two-way
ANOVA, significant corticosterone treatment  reinstatement
condition interaction: F(3,15) 20.997; p 0.001).When admin-
istered alone, neither corticosterone nor low-dose cocaine pro-
duced significant reinstatement. However, the combination of
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corticosterone pretreatment followed by low-dose cocaine pro-
duced robust reinstatement (p 0.003 vs extinction).
Role of the glucocorticoid receptor in corticosterone-induced
potentiation of drug-seeking
Although many actions of corticosteroids require activation of
the GR, some acute actions appear to be mediated by GR-
independentmechanisms (Di et al., 2003). To determine the con-
tribution of GR-dependent signaling to corticosterone effects on
reinstatement, we examined the effects of pretreatment with the
GR antagonist RU486 on corticosterone-induced potentiation of
cocaine-primed reinstatement. In reinstatement studies, pre-
treatment with RU486 (12.5 mg/kg, s.c.) failed to block the po-
tentiation of low-dose cocaine-induced reinstatement by
corticosterone administration (Fig. 1D). Once again, corticoste-
rone potentiated reinstatement after low-dose cocaine adminis-
tration (three-way ANOVA, significant corticosterone 
reinstatement condition interaction: F(1,9) 11.141, p 0.009).
RU-486 treatment did not disrupt this effect (significant main ef-
fects or interactions involving RU-486 were not found), indicating
that corticosterone’s potentiating action involves a GR-
independent, nongenomicmechanism. To confirm that the dose of
RU486 (12.5 mg/kg) used in this study resulted in occupation of
central GR, we examined the effects of RU486 on subcellular local-
ization of GR in hippocampal cells using immunofluorescence.
Consistent with previous studies demonstrating that RU486 trans-
locates hippocampal GR from cytosolic to
nuclear fractions (Spiga et al., 2010),GR im-
munostaining in thehippocampiofRU486-
treated rats was concentrated in cell nuclei,
whereas GR in vehicle-treated rats was ob-
served as diffuse cellular staining (data not
shown), indicating that treatment with
RU486 at this dose and via this route of ad-
ministration resulted in occupation of cen-
tral GR.
Corticosterone-dopamine interactions
in the NAc underlie potentiation
of reinstatement
Activation of dopamine receptors in sub-
regions of theNAc is sufficient to reinstate
drug seeking in rats (Cornish and Kalivas,
2000; Bachtell et al., 2005; Schmidt et al.,
2006), and the magnitude of the cocaine-
induced increase in accumbens dopamine
appears to be a key determinant of the
magnitude of reinstatement (Madayag et
al., 2010). Previous reports have demon-
strated that evoked increases in NAc
dopamine are enhanced when corticoste-
rone is elevated to stress concentrations at
the time of testing (Piazza et al., 1996;
Deroche et al., 1997; Marinelli et al.,
1997), suggesting that the potentiating ef-
fects of corticosterone and stress on co-
caine seeking may involve augmentation
of theNAc dopamine response to cocaine.
To test this hypothesis, we used in vivo
microdialysis to examine the effects of
stress-level corticosterone treatment on
cocaine-induced increases in extracellular
dopamine concentrations in theNAc. Fig-
ure 2A illustrates extracellular dopamine levels in the NAc before
and after intraperitoneal injection of low-dose cocaine (2.5 mg/
kg) in animals pretreated with stress-level corticosterone (2 mg/
kg, i.p.) or vehicle. Cumulative postcocaine extracellular
dopamine levels (calculated as areas under the curve using all
postcocaine samples) were significantly higher in corticosterone-
pretreated rats relative to vehicle controls (Fig. 2B; unpaired
t test, t(23) 1.793, p 0.043).
Based on these findings, we hypothesized that the observed
corticosterone-potentiated increase in NAc dopaminergic neu-
rotransmission was responsible for the potentiating effects of
corticosterone on cocaine-induced reinstatement. To test this
hypothesis, we examined the effects of bilateral intra-accumbens
infusions of the nonselective dopamine receptor antagonist flu-
phenazine or vehicle on corticosterone-induced potentiation of
cocaine-primed reinstatement. Intra-accumbens fluphenazine
treatment prevented the increase in reinstatement that was ob-
served when rats received both corticosterone and low-dose
cocaine (Fig. 3A; two-way ANOVA; significant treatment  re-
instatement condition interaction: F(1,12)  6.007; p  0.031).
Low-dose cocaine administration after corticosterone pretreat-
ment reinstated cocaine seeking after delivery of vehicle (p 
0.007), but not fluphenazine, into the NAc. Subgroups of rats
received injections targeting the NAc core and shell. Because the
effects of fluphenazine on reinstatement did not differ between
Figure 1. Stress potentiates cocaine-induced drug-seeking behavior by a corticosterone-dependent, GR-independent mecha-
nism. A, B, Cocaine lever responses on the last day of extinction and during reinstatement testing of (A) adrenal-intact (n 7) or
(B) adrenalectomized (ADX; n 6) rats. On the day of reinstatement testing, rats were subjected to 15 min of uncontrollable,
intermittent electric footshock (EFS) or no shock, followed by injection of cocaine (2.5 mg/kg, i.p.) or saline, and cocaine lever
responses were recorded for 2 h. C, Cocaine lever responses on the last day of extinction and during reinstatement testing. Rats
(n 6) received an injection of corticosterone (CORT; 2.0 mg/kg, i.p.) or vehicle, followed 40 min later by an injection of cocaine
(2.5mg/kg, i.p.) or saline.D, Cocaine lever responses on the last day of extinction and during reinstatement testing. Rats (n 10)
received an injection of the glucocorticoid receptor antagonist RU38486 (12.5 mg/kg, s.c.) or vehicle, followed 60 min later by
injection of corticosterone (2.0 mg/kg, i.p.) or vehicle, followed 40 min later by an injection of cocaine (2.5 mg/kg, i.p.) (see also
Table 1). *p 0.05, significantly different from extinction responding. Error bars represent mean SEM.
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these two brain regions, data from the two regions were com-
bined for analysis.
Corticosterone acts in the NAc to potentiate reinstatement
Because we found that (1) corticosterone acutely potentiates
cocaine-induced increases in extracellular dopamine in the NAc
and (2) dopaminergic neurotransmission in the NAc is necessary
for corticosterone-induced potentiation of behavior, we sought
to determine whether corticosterone actions within the NAc are
sufficient to promote reinstatement. To accomplish this, we
tested the ability of intra-accumbens corticosterone infusions to
reproduce the effects of systemic corticosterone or footshock on
low-dose cocaine-induced reinstatement. As was the case with
the fluphenazine study, subgroups of rats received infusions of
corticosterone or vehicle into the NAc shell or core; and because
the effects of corticosterone administered into the shell or core
did not differ, data from the two regions were combined for
analysis. As in the systemic corticosterone experiments, neither
low-dose cocaine (after intra-accumbens vehicle) nor intra-
accumbens corticosterone (before intraperitoneal saline admin-
istration) reinstated cocaine seeking when administered alone.
However, when rats received bilateral intra-accumbens cortico-
sterone before administration of low-dose cocaine, significant
reinstatement was observed (two-way ANOVA, significant treat-
ment reinstatement condition interaction: F(2,22) 4.182; p
0.029; post hoc testing p 0.01 vs extinction) (Fig. 3B).
Effects of acute corticosterone treatment on dopamine
clearance in the NAc
Together, our results demonstrate that corticosterone acutely po-
tentiates cocaine-induced dopamine signaling in the NAc and
that this potentiation promotes cocaine seeking. However, corti-
costerone alone has no effect on extracellular dopamine and does
not induce cocaine seeking. Further, this effect appears to occur
independently of GR activation, suggesting a rapid, nongenomic
mechanism of action. Such a mechanism, which would enhance
cocaine effects on dopaminergic neurotransmission without di-
rectly driving increases in dopamine, could involve either inhibi-
tion of dopamine metabolism or of transporter-mediated
clearance. Corticosteroids have long been known to acutely block
catecholamine clearance mediated by uptake2, a high-capacity
monoamine transport system originally described in peripheral
tissues (Iversen and Salt, 1970). Uptake2 activity has more re-
cently been attributed to a group of broadly specific transporters,
including the organic cation transporter (OCT) family (OCTs 1,
2, and 3) and the plasma membrane monoamine transporter
Figure 2. Corticosterone potentiates cocaine-induced increases in extracellular dopamine concentrations in the NAc. A, In vivomicrodialysis was used to measure extracellular dopamine levels
in theNAc in drug-naive rats. After collection of baseline samples, rats received an injection of corticosterone (2.0mg/kg, i.p.; n 13;F) or vehicle (n 12;E) at the time indicated. Fortyminutes
later, all animals received an injection of cocaine (2.5 mg/kg, i.p.). Data represent mean dopamine concentrations at each time point. B, Cumulative dopamine (area under the curve) during the
postcocaine period (t 40–160min). *p 0.05, significantly different from the vehicle group (unpaired t test). C, Black lines indicate the locations of the microdialysis probes aimed at the NAc.
Figure 3. Dopamine-dependent actions in the NAc underlie corticosterone-induced potentiation of drug-seeking behavior. A, Cocaine lever responses on the last day of extinction and during
reinstatement testing. Rats (n 13) received an intraperitoneal injection of corticosterone (2 mg/kg). After 25 min, all animals received intra-accumbens injections of fluphenazine (30 nmol/0.3
l) or vehicle followed, 15 min later, by an intraperitoneal cocaine injection (2.5 mg/kg). *p 0.05, significantly different from extinction responding. #p 0.05, significantly different from
reinstatement responding after vehicle treatment. ns, Not significant.B, Cocaine lever responses on the last day of extinction and during reinstatement testing. On the day of reinstatement testing,
rats (n 12) received intra-accumbens injections of corticosterone (CORT, 0.05 g/0.3 l) followed, 15 min later, by an intraperitoneal injection of saline or cocaine (2.5 mg/kg). *p 0.05,
significantly different from extinction responding). C, Locations of microinjection sites from animals used in A and B.
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(PMAT). All of these transporters are capable of transporting,
with varying efficiencies, dopamine and other monoamines
(Grundemann et al., 1998b; Shang et al., 2003; Gorboulev et al.,
2005; Schomig et al., 2006; Duan andWang, 2010) and, with the
exception of OCT1, all are expressed in the brain (Engel et al.,
2004; Vialou et al., 2004; Amphoux et al., 2006; Gasser et al.,
2009). Although all are sensitive to inhibition by corticosterone,
their sensitivities vary widely. PMAT is the least sensitive to cor-
ticosterone (Ki 450 M), followed by OCT1 (IC50 150 M),
OCT2 (IC50 5 M), and OCT3 (IC50 0.04–0.2 M) (Grun-
demann et al., 1998b; Shang et al., 2003; Gorboulev et al., 2005;
Schomig et al., 2006; Duan andWang, 2010). Recent studies have
demonstrated that corticosterone inhibition of OCT-mediated
transport occurs by direct binding to the transporter, through a
GR-independent, nongenomic mechanism (Grundemann et al.,
1999; Horvath et al., 2003; Gorboulev et al., 2005).
To test the hypothesis that the potentiation of cocaine-primed
reinstatement by corticosterone involves blockade of dopamine
clearance, we used fast-scan cyclic voltammetry, an electrochem-
ical technique with the temporal resolution necessary for resolv-
ing dopamine release and uptake (Wightman et al., 1988).
Dopamine release was electrically evoked in anesthetized rats by
stimulating dopamine neurons in the ventral tegmental area
while uptake was measured in the NAc shell under transport
saturating conditions, permitting Michaelis-Menten kinetic
modeling (Wightman et al., 1988; Yorgason et al., 2011). Electri-
cally evoked dopamine release and uptake were measured in the
NAc in drug naive rats to establish a baseline (Fig. 4). All rats then
received an injection of GBR12909 (15 mg/kg, i.p.), an inhibitor
that, unlike cocaine, selectively blocks the dopamine transporter
(DAT) and reliably reduces dopamine clearance (Andersen,
1989; Park et al., 2010). We observed the GBR12909-induced
reduction in DA clearance to be stable on a time scale consistent
with previous reports (Budygin et al., 2000; Espana et al., 2008;
Park et al., 2010), and we verified stability of the pharmacological
effect of GBR12909 as a persistent increase in both amplitude and
duration of the stimulated dopamine signal. After stabilization of
the response, rats received an additional injection either of corti-
costerone (2 mg/kg), or vehicle to test the hypothesis that corti-
costerone treatment would further augment the dopamine
signal.
Electrical stimulation of dopamine neurons in the VTA reli-
ably induced dopamine release in the NAc (Fig. 4B). This effect
was augmented by blocking the DAT with GBR12909. After sta-
bilization of the GBR effect, injection of corticosterone at a dose
that reproduces stress-induced plasma levels (Table 1) further
Figure 4. Corticosterone administration decreases dopamine uptake after DAT blockade. A, NAc recording sites for dopamine uptake measurements in vehicle-treated (E) and corticosterone-
treated (F) rats.B, Experimental design and example of two-dimensional color representation of cyclic voltammetric data collected for 20 s around a single stimulation. The ordinate is the applied
voltage (Eapp), and the abscissa is time (in seconds). Changes in current at the carbon-fiber electrode are indicated in color. After 10 baseline stimulations (white horizontal lines), rats were injected
with GBR12909 (15 mg/kg) and stimulated until stabilization of the drug response (center color plot). Rats were then either injected with corticosterone (2 mg/kg, n 5, right color plot, top), or
vehicle (n 5, right color plot, bottom). C, Measures of dopamine uptake. D–F, Mean SEM change in measures of uptake after corticosterone treatment (D, FWHH; E, ; and F, apparent Km),
compared with vehicle-injected controls. *p 0.05, compared with vehicle (Student’s unpaired t test).
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augmented the dopamine signal (Fig.
4B–D; Table 2). Kinetics of dopamine
transport were modeled with the Demon
Voltammetry and Analysis software suite.
Several measures of uptake were analyzed
(Fig. 4; Table 2) with each measure in
agreement, consistent with previous stud-
ies (Yorgason et al., 2011). Corticosterone
treatment significantly increased full-
width at half-height (t(8)  4.375, p 
0.002, Fig. 4D),  (t(8)2.643, p 0.03,
Fig. 4E), and apparent Km (t(8)3.804,
p  0.005, Fig. 4F), compared with
vehicle-injected controls, indicating a re-
duction in dopamine clearance.
Intra-accumbens normetanephrine
potentiates
cocaine-induced drug seeking
Although the results of the voltammetry
studies strongly suggest that corticoste-
rone acts at least in part by inhibiting do-
pamine clearance, there are additional
GR-independent mechanisms through
which glucocorticoids may alter neurotransmission (Di et al.,
2003). To more rigorously test our hypothesis that uptake inhi-
bition mediates the potentiating effects of stress and corticosterone
on cocaine seeking, we examined the ability of intra-accumbens ad-
ministration of normetanephrine, the O-methylated metabolite of
norepinephrine and a potent nonglucocorticoid inhibitor of
uptake2-mediated transport (Martel et al., 1999), to reproduce the
effects of corticosterone and footshock on low-dose cocaine-
induced reinstatement. Although normetanephrine has been re-
ported to act as a weak agonist at 1-adrenergic receptors (Langer
and Rubio, 1973), to our knowledge the sole overlapping mecha-
nism of action between normetanephrine and glucocorticoids is
blockade of uptake2-mediated transport. Based on our demonstra-
tion that corticosterone decreased dopamine clearance in the NAc
shell, and on our previous studies demonstrating that, although
OCT3 is expressed in both the shell and core of the NAc, it is ex-
pressedmore densely in the shell (Gasser et al., 2009), our injections
of normetanephrine were targeted to the shell (Fig. 5). Like intra-
accumbens corticosterone, intra-accumbens normetanephrine
potentiated low-dose cocaine-induced reinstatement but had no ef-
fect on cocaine seeking when administered alone (two-way
ANOVA, significant treatment reinstatement condition interac-
tion: F(2,8) 8.765; p 0.01) (Fig. 5). Post hoc testing indicated that
intra-accumbens normetanephrine infusions potentiated cocaine-
induced reinstatement (p 0.01 vs extinction).
OCT3 is expressed on NAc neurons
The uptake2 transporters vary widely in their sensitivity to inhi-
bition by corticosterone.Of these transporters, OCT3 is by far the
most sensitive to inhibition by corticosterone and is the only
transporter inhibited by corticosterone at physiological concen-
trations (Shang et al., 2003; Gorboulev et al., 2005; Gasser et al.,
2006; Duan andWang, 2010; Hill et al., 2011). Thus, we hypoth-
esized that the acute corticosterone-induced inhibition of dopa-
mine clearance in theNAc reported here is the result of inhibition
of OCT3-mediated transport. Although our previous studies iden-
tified OCT3-expressing cells in the NAc (Gasser et al., 2009), the
identity of these cells is unknown, and there is no information avail-
able about the distribution of OCT3 with respect to dopaminergic
terminals and dopamine receptors. In the present studies, we used
immunofluorescence techniques toconfirmtheexpressionofOCT3
in theNAc, to identify the phenotype ofOCT3-expressing cells, and
todescribe the localizationofOCT3 immunoreactivity in relation to
dopaminergic terminals and dopamine receptors in the region.
OCT3-like immunoreactivity was observed as punctae distributed
throughout the NAc core and shell, and was also concentrated in
small-diameter (8–10 m) perikarya (Fig. 6). Staining was not ob-
served in sections incubated in the absence of the OCT3 antibody
(data not shown). In both regions, OCT3-ir punctae were observed
in closeproximity to, butnot colocalizedwith, tyrosinehydroxylase-
immunoreactive fibers (Fig. 6A,B), andwereobserved incloseprox-
imity to dopamineD1 receptor-immunoreactive punctae (Fig. 6C).
OCT3-immunoreactive perikarya also displayed immunoreactivity
for the neuron-specific cytoskeletal marker -III tubulin (Fig. 6D).
Discussion
Our findings provide new insight into the mechanisms by which
stressful life events increase the likelihood of relapse in recovering
addicts. The data establish that acute stress potentiates the effects
of low-dose cocaine on drug-seeking behavior in rats, and iden-
tify corticosterone as a necessary mediator of this potentiating
interaction. They identify the NAc as a critical site at which
corticosterone acts to potentiate cocaine effects on dopaminergic
signaling and reinstatement. They demonstrate that corticoste-
rone acutely decreases dopamine clearance within the NAc, and
Figure 5. Normetanephrine potentiates cocaine-induced drug-seeking behavior. A, Effects of intra-accumbens normetaneph-
rine on cocaine-primed reinstatement. Rats (n 6) received bilateral infusions of normetanephrine (25 ng/0.3 l) or vehicle
(aCSF) followed, 15 min later, by an injection of cocaine (2.5 mg/kg, i.p.) or saline. Data represent mean SEM of active lever
responding over the 2h immediately after the second injection. Significant increases in active lever respondingwere observed only
when animals had received both normetanephrine and cocaine. *p 0.05, compared with all other groups. B, Locations of
microinjection sites from animals used in B.
Table 2. Summary of treatment effects onmeasures of dopamine clearance in the NAc
 Full-width at
half-height (s)  Tau (s)  Apparent Km (nM)  Half-life (ms)  t20 (ms)  t80 (ms)
 Peak height
	DA
 (nM)
Vehicle 0.102 (0.06931) 0.036 (0.05887) 86.118 (96.09) 0.02 (0.03937) 0.018 (0.09074) 0.094 (0.09796) 0.68 (0.16775)
Corticosterone 0.48 (0.11353) 0.532 (0.2067) 492.282 (117.814) 0.368 (0.14267) 0.284 (0.09293) 1.122 (0.51043) 0.69 (0.51905)
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provide evidence that corticosterone acts by inhibiting the high-
capacity monoamine transporter OCT3. We conclude that
corticosterone-induced inhibition of dopamine clearance in-
creases sensitivity to the effects of cocaine on dopaminergic neu-
rotransmission and behavior and may represent a fundamental
mechanism through which stress modulates dopaminergic neu-
rotransmission, resulting in alterations in motivated behavior.
Although acute stress can, under certain conditions, act as a
primary trigger for the reinstatement of drug-seeking behavior
(Erb et al., 1998; Graf et al., 2011), it has been proposed that stress
more often acts as a “stage-setter,” increasing the likelihood of
relapse in response to other drug-associated stimuli (Preston and
Epstein, 2011). The present studies model the stage-setting ac-
tions of stress and demonstrate that, even under conditions when
stress alone does not trigger reinstatement, it can potentiate
reinstatement in response to another subthreshold stimulus.
Furthermore, these studies demonstrate that the stage-setting
actions of stress are mediated by a mechanism distinct from that
underlying reinstatement triggered by stress alone. Specifically,
reinstatement induced primarily by stress does not require in-
creases in corticosterone to stress levels (Erb et al., 1998; Graf et
al., 2011). In contrast, the potentiation of cocaine-induced rein-
statement by stress requires elevation of corticosterone to stress
levels, and treatment with stress levels of corticosterone in the
absence of stress is sufficient to potentiate cocaine-induced rein-
statement. Thus, although stress-induced increases in corticoste-
rone do not by themselves drive reinstatement of drug-seeking
behavior, they appear to enhance sensitivity to other relapse-
promoting stimuli. This may represent an important mechanism
by which stress influences the likelihood of relapse in recovering
addicts. Given that a history of exposure to cocaine and other
drugs of abuse can alter HPA axis function (for review, see Kreek
and Koob, 1998) and determines the pattern and magnitude of
drug seeking and/or self-administration (Ahmed and Koob,
1998; Mantsch et al., 2008), the present findings suggest the fol-
lowing: (1) altered HPA reactivity and glucocorticoid regulation
of dopamine clearance may contribute to the transition to com-
pulsive use that defines addiction; and (2) the contribution of this
mechanism to drug use may vary depending on the drug and the
phase of the addiction process.
Our data indicate that corticosterone enhances the behavioral
effects of low-dose cocaine by potentiating cocaine-induced in-
creases in NAc dopamine. Dopamine signaling in the NAc is an
important contributor to cocaine-induced reinstatement of drug
seeking (Cornish and Kalivas, 2000; Bachtell et al., 2005; Schmidt
et al., 2006); and themagnitude of cocaine-primed reinstatement
appears to be determined in part by the level of extracellular
dopamine in the NAc (Madayag et al., 2010). Our findings are
consistent with this model and strongly suggest that the potenti-
ation of relapse by stress or corticosterone is mediated by aug-
mentation of cocaine-induced increases inNAc dopamine. In the
present studies, noncontingent injection of low-dose cocaine was
insufficient either to elevate NAc dopamine or to induce rein-
statement of compulsive drug-seeking unless it was preceded by
elevation of corticosterone to stress levels, either by acute stress
exposure or by corticosterone injection. Furthermore, elevation
of corticosteronewithin theNAcwas sufficient to potentiate sub-
threshold cocaine-induced reinstatement, and the ability of sys-
temic corticosterone to potentiate cocaine-primed reinstatement
was eliminated by intra-accumbens blockade of dopamine recep-
tors. These results are consistent with previous studies demon-
strating that removal of corticosterone by adrenalectomy or
metyrapone treatment blunts cocaine-induced increases in NAc
dopamine (Rouge-Pont et al., 1995; Barrot et al., 2000).
Our finding that stress-level corticosterone treatment po-
tentiated cocaine-induced increases in NAc dopamine, but
had no effect on its own, is consistent with the results of pre-
vious studies demonstrating that corticosterone-induced in-
creases in striatal dopamine concentrations are state-dependent
(Piazza et al., 1996). This state dependency led to the hypothesis
that corticosterone does not directly stimulate dopamine release
in the NAc but rather acts indirectly to enhance dopaminergic
Figure 6. OCT3 is expressed proximal to dopamine terminals and D1 receptors in the NAc. A, B, Representative photomicrographs depicting immunostaining for OCT3 (red) and tyrosine
hydroxylase (green) in adult rat NAc core (A) and shell (B). C, Immunostaining for OCT3 (red) and dopamineD1 receptor (green) in NAc core. Square in C indicates area shown at highermagnification
in the inset. D, Immunostaining for OCT3 (red) and the neuronal marker B-III tubulin (green) in NAc core. E, Line drawing (adapted from Paxinos andWatson, 1998) of a coronal section containing
the areas of the NAc used for immunostaining and depicted in the indicated panels. Labeled black rectangles indicate the approximate locations fromwhich the images were acquired. Scale bars:
A, B, 33.3m; C, D, 20m; D inset, 6.75m.
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responses to other stimuli (e.g., by inhibiting catabolic enzymes
or uptake mechanisms) (Piazza et al., 1996). Under this hypoth-
esis, corticosterone effects on NAc dopamine would require a
threshold level of activity of dopaminergic inputs. Below this
threshold, corticosterone would have little effect on dopamine
concentrations.
The results of our voltammetry studies demonstrate that cor-
ticosterone treatment rapidly decreases dopamine clearance in
the NAc. This is consistent with previous ex vivo findings that
glucocorticoids rapidly decrease the uptake of dopamine by
crude striatal synaptosomes (Gilad et al., 1987), a preparation
that contains both presynaptic and postsynaptic compartments.
The rapidity with which glucocorticoids decreased uptake in our
studies and in the ex vivo studies indicates that corticosterone-
induced decreases in dopamine clearance involve a nongenomic
mechanism. This is consistent with our finding that the GR antago-
nist RU38486 did not block corticosterone-induced potentiation of
cocaine-primed reinstatement. The ability of corticosterone to de-
crease dopamine clearance in animals in which the activity of the
DATwas inhibitedby treatmentwitha saturatingdoseofGBR12909
indicates that corticosterone-sensitive dopamine clearance does not
involve the DAT. These findings suggest that corticosterone de-
creases extracellular dopamine clearance either by inhibiting dopa-
mine catabolism or by blocking a non-DAT dopamine transporter.
Although recent studies have demonstrated acute glucocorticoid-
induced decreases inmonoamine oxidase protein and activity, these
effects were only observed after 2–4 h of glucocorticoid exposure
(Soliman et al., 2012), well beyond the time points formeasurement
of uptake and behavior in the current studies. Thus, the most likely
mechanism involves inhibition of dopamine transport.
Our finding that intra-accumbens administration of
normetanephrine, a nonglucocorticoid inhibitor of uptake2-
mediated transport (Martel et al., 1999), mimicked the effects of
corticosterone on cocaine-induced reinstatement, strongly sug-
gests that the behavioral and physiological effects of corticoste-
rone reported here result fromcorticosterone-induced inhibition
of dopamine clearance mediated by an uptake2 transporter. Up-
take2 is a high-capacity, corticosteroid-sensitive monoamine
transport system originally described in peripheral tissues
(Iversen and Salt, 1970). Recent studies have identified a small
group of transporters, including OCTs 1, 2, and 3 and PMAT, as
mediators of uptake2-like monoamine transport and have dem-
onstrated their expression in the brain (Engel et al., 2004; Vialou
et al., 2004; Amphoux et al., 2006). Of these transporters, OCT3
and PMAT transport dopamine with the greatest efficiency,
whereas OCT1 and 2 are not thought to transport dopamine
under physiological conditions (Grundemann et al., 1998a, b,
1999; Engel et al., 2004; Duan andWang, 2010; Bacq et al., 2011).
OCT3 and PMAT transport dopamine with similar efficiencies,
but they differ markedly in sensitivity to inhibition by corticoste-
rone. Whereas the IC50 for corticosterone inhibition of OCT3-
mediated transport (0.04–0.2 M) (Shang et al., 2003) is within
the physiological range reported for stress-induced concentra-
tions of corticosterone in the brain (Droste et al., 2008), PMAT-
mediated transport is inhibited only at very high concentrations
of corticosterone (Ki 450 M) (Duan and Wang, 2010). Based
upon these properties, we hypothesize that OCT3 inhibition un-
derlies the effects of stress level corticosterone treatment on do-
pamine clearance and cocaine-seeking behavior in the present
studies. Definitive testing of this hypothesis will require the ex-
amination of stress and corticosterone effects on drug-seeking
behavior and dopamine clearance in OCT3-deficient animals.
Consistent with our hypothesis, OCT3-deficientmice exhibit en-
hanced behavioral and neurochemical responses to metham-
phetamine and cocaine (Vialou et al., 2008; Cui et al., 2009).
The results of our immunofluorescence studies suggest that
OCT3 represents a postsynaptic dopamine clearance mechanism
in the NAc. We confirmed the expression of OCT3 in the core
and shell of the rat NAc, and we began to characterize the pheno-
type of OCT3-expressing cells and the subcellular localization of
OCT3 in this area. Our observations indicate that OCT3 is ex-
pressed on the somata and processes of postsynaptic, likely me-
dium spiny neurons in the NAc, and not on dopaminergic
terminals. As in the amygdala (Hill and Gasser, 2013), OCT3 in
the NAc is localized in close proximity to D1 receptors. These
findings raise the interesting possibility that OCT3 represents a
previously uncharacterized postsynaptic dopamine clearance
mechanism, and make OCT3 a compelling mechanism through
which glucocorticoids may act to potentiate cocaine effects on
dopaminergic neurotransmission and behavior. Additional stud-
ies, including electron microscopic examination, are required to
more clearly identify the subcellular localization of OCT3.
The effects of stress on motivated behavior are powerful, per-
vasive, and context-dependent, suggesting complex interactions
between stress-response systems and the circuitry underlying
motivated behavior.However, rather thandriving specific behav-
iors, stress often modulates ongoing behaviors in a context-
dependent manner. We have demonstrated a central role for
glucocorticoid hormones in the heightened susceptibility to drug
relapseduring timesof stress, andwehave identifiedamechanismby
which stress-level glucocorticoids act in the NAc to decrease dopa-
mine clearance, enhancing the effects of cocaine on dopaminergic
neurotransmission and behavior. This may represent a general
mechanismbywhich stress, by elevating glucocorticoids,modulates
ongoing behavior, shaping appropriate responses to environmental
stimuli.
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